Exploring the Potential of Combining Engineered iPSC NK Cells with NK cell Engagers & the Future of Cell Therapies

Time: 12:00 pm
day: Focus Day - Track B - Afternoon


  • Advantages of IPSC derived NK products vs NK cell line, donor derived, or cord blood
  • Advantages of NK cell therapies over CAR-T cell therapies
  • Advantages of TALEN over CRISPR